The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.
Open accessAbstract
We have reviewed all known UK cases of Smith-Lemli-Opitz syndrome. Among 49 cases with proven 7-dehydrocholesterol reductase deficiency, half had been terminated or had died in infancy. The minimum incidence is 1 in 60,000. The frequent occurrence of hypospadias may account for 71% of recognised cases being male. Important common features which emerged include short thumbs, severe photosensitivity, aggressive behaviour, and atrioventricular septal defect. The typical facial appearance becomes less obvious with age and 20% of cases did not have 2/3 toe syndactyly. Biochemical measurements of serum 7-dehydrocholesterol did not correlate with clinical severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome
Tint, G. S., Irons, M., Elias, E. R., Batta, A. K., Frieden, R., Chen, T. S., & Salen, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401133300205 · Cited by 798
A newly recognized syndromeof multiple congenital anomalies
Smith, D. W., Lemli, L., & Opitz, J. M. (1964) · The Journal of Pediatrics · doi:10.1016/s0022-3476(64)80264-x · Cited by 650
Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome
Irons, M., Roy Elias, E., Salen, G., Tint, G. S., & Batta, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90983-n · Cited by 368
Kelley, R. I. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06038-4 · Cited by 234
Cited by
The genetics of autistic disorders and its clinical relevance: a review of the literature
Freitag, C. M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001896 · Cited by 638
The Smith-Lemli-Opitz syndrome
Kelley, R. I., & Hennekam, R. C. M. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.5.321 · Cited by 480
Malformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
Belmonte, M. K., Cook, E. H., Anderson, G. M., Rubenstein, J. L. R., Greenough, W. T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L. M., Powell, S. B., Levitt, P. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001499 · Cited by 442
Specific Genetic Disorders and Autism: Clinical Contribution Towards their Identification
Cohen, D., Pichard, N., Tordjman, S., Baumann, C., Burglen, L., Excoffier, E., Lazar, G., Mazet, P., Pinquier, C., Verloes, A., et al. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-004-1038-2 · Cited by 316
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models
Chrast, R., Saher, G., Nave, K.-A., & Verheijen, M. H. G. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009761 · Cited by 314
Cholesterol in myelin biogenesis and hypomyelinating disorders
Saher, G., & Stumpf, S. K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.02.010 · Cited by 192
Wassif, C. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.555 · Cited by 164
Cholesterol: A Novel Regulatory Role in Myelin Formation
Saher, G., Quintes, S., & Nave, K.-A. (2011) · The Neuroscientist · doi:10.1177/1073858410373835 · Cited by 144
3β-Hydroxysterol Δ7-reductase and the Smith–Lemli–Opitz syndrome
Correa-Cerro, L. S., & Porter, F. D. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.09.017 · Cited by 92
Pathogenesis, epidemiology, diagnosis and clinical aspects of smith-lemli-opitz syndrome
Bianconi, S. E., Cross, J. L., Wassif, C. A., & Porter, F. D. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1014472 · Cited by 84
Autism: The role of cholesterol in treatment
Aneja, A., & Tierney, E. (2008) · International Review of Psychiatry · doi:10.1080/09540260801889062 · Cited by 82
Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update
Thurm, A., Tierney, E., Farmer, C., Albert, P., Joseph, L., Swedo, S., Bianconi, S., Bukelis, I., Wheeler, C., Sarphare, G., et al. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9145-x · Cited by 73
Segatto, M., Leboffe, L., Trapani, L., & Pallottini, V. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140303142902 · Cited by 65
Nowaczyk, M., & Waye, J. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.590601.x · Cited by 61
Brain magnetic resonance imaging findings in Smith-Lemli-Opitz syndrome
Lee, R. W. Y., Conley, S. K., Gropman, A., Porter, F. D., & Baker, E. H. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36096 · Cited by 54
“The incidence is estimated to be 1 in 20,000–60,000 live births [Lowry and Yong, 1980; Ryan et al., 1998; Bzduch et al., 2000; Kelley and Hennekam, 2000].”
BackgroundSegatto, M., Tonini, C., Pfrieger, F. W., Trezza, V., & Pallottini, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133317 · Cited by 51
MRI and 1H MRS findings in Smith-lemli-opitz syndrome
Caruso, P. A., Poussaint, T. Y., Tzika, A. A., Zurakowski, D., Astrakas, L. G., Elias, E. R., Bay, C., & Irons, M. B. (2004) · Neuroradiology · doi:10.1007/s00234-003-1110-1 · Cited by 51
Hypothesis: The Role of Sterols in Autism Spectrum Disorder
Lee, R. W. Y., & Tierney, E. (2011) · Autism Research and Treatment · doi:10.1155/2011/653570 · Cited by 30
Relation between biomarkers and clinical severity in patients with Smith–Lemli–Opitz syndrome
Oláh, A. V., Szabó, G. P., Varga, J., Balogh, L., Csábi, G., Csákváry, V., Erwa, W., & Balogh, I. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-012-1925-z · Cited by 22
Growth charts for individuals with Smith-Lemli-Opitz syndrome
Lee, R. W. Y., McGready, J., Conley, S. K., Yanjanin, N. M., Nowaczyk, M. J. M., & Porter, F. D. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35376 · Cited by 20
Metadata
- Authors
- Ryan, A. K., Bartlett, K., Clayton, P., Eaton, S., Mills, L., Donnai, D., Winter, R. M., & Burn, J.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 1998-07
- Volume
- 35
- Issue
- 7
- Pages
- 558-565
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2059172428
- Cited by
- 231
- References
- 4
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.